Audited Results of Neuland Laboratories Ltd. Company

(Rs in Cr.)	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Operating Income	1,476.84	1,558.58	1,191.20	951.08	936.91
Manufacturing Expenses	101.45	98.72	84.93	79.80	76.78
Personnel Expenses	261.40	248.53	194.84	175.76	144.02
Selling Expenses	17.30	11.78	8.84	6.82	2.47
Administrative Expenses	125.34	102.55	102.43	72.81	85.28
Expenses Capitalised	0	0	0	0	0
Cost Of Sales	1,154.54	1,096.66	919.89	808.88	790.47
Operating Profit	322.30	461.92	271.31	142.19	146.44
Other Recurring Income	20.51	12.54	9.75	2.08	16.09
Adjusted PBDIT	342.81	474.47	281.06	144.27	162.54
Financial Expenses	8.30	14	13.07	13.49	17.90
Depreciation	65.54	59.70	52.78	49.04	39.68
Other Write offs	0	0	0	0	0
Adjusted PBT	268.97	400.77	215.21	81.74	104.96
Tax Charges	85.95	101.17	52.09	18.21	24.67
Adjusted PAT	183.02	299.60	163.12	63.53	80.29
Non Recurring Items	76.40	0	0	0	0
Other Non Cash adjustments	0	0	0	0	0
Reported Net Profit	259.43	299.60	163.12	63.53	80.29
Equity Dividend	17.96	12.83	6.41	3.85	2.57
Preference Dividend	0	0	0	0	0
Retained Earnings	988.77	747.31	460.54	303.84	244.15

Disclaimer: This is 3rd Party content/feed, viewers are requested to use their discretion and conduct proper diligence before investing, GoodReturns does not take any liability on the genuineness and correctness of the information in this article